The effects of the COVID-19 pandemic on patients with obsessive-compulsive disorder.

Raşit Tükel, Oğuzhan Başaran, Simge Ergün, Mourat Giousouf Chousein, Mesut Keskin, Erhan Ertekin
{"title":"The effects of the COVID-19 pandemic on patients with obsessive-compulsive disorder.","authors":"Raşit Tükel,&nbsp;Oğuzhan Başaran,&nbsp;Simge Ergün,&nbsp;Mourat Giousouf Chousein,&nbsp;Mesut Keskin,&nbsp;Erhan Ertekin","doi":"10.1080/13651501.2022.2082984","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Little is known about the impact of the COVID-19 pandemic on obsessive-compulsive disorder (OCD). The main aim of this study was to investigate how the pandemic has affected OCD patients and the relationship between the clinical features and the fear and obsession with COVID-19.</p><p><strong>Methods: </strong>A total of 30 consecutive patients with OCD and 30 age-and sex-matched healthy controls were included in this cross-sectional study. Based on retrospective information provided by the patients, we evaluated changes in the severity of their OCD during the pandemic compared to the pre-pandemic period. We compared patients with OCD and healthy subjects using scores obtained from various scales.</p><p><strong>Results: </strong>We found that symptom severity worsened in 60% of OCD patients during the pandemic compared to the pre-pandemic period, remained unchanged in 30%, and improved in 10%. The levels of obsession with COVID-19 were found to be higher in OCD patients than in healthy control subjects. The levels of fear of and obsession with COVID-19 both correlated with the anxiety levels of patients with OCD and healthy controls.</p><p><strong>Conclusions: </strong>Our results suggest that the levels of COVID-19 related fear and obsession are not linked to the severity of OCD, but to anxiety levels. Key pointsObsessive-compulsive symptom severity worsened in 60% of OCD patients in the pandemic.COVID-19 obsession levels were higher in OCD patients than healthy controls.COVID-19 fear levels did not differ between the OCD and healthy control groups.COVID-19 obsession levels were correlated with anxiety severity in OCD and healthy control groups.</p>","PeriodicalId":14351,"journal":{"name":"International Journal of Psychiatry in Clinical Practice","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry in Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13651501.2022.2082984","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: Little is known about the impact of the COVID-19 pandemic on obsessive-compulsive disorder (OCD). The main aim of this study was to investigate how the pandemic has affected OCD patients and the relationship between the clinical features and the fear and obsession with COVID-19.

Methods: A total of 30 consecutive patients with OCD and 30 age-and sex-matched healthy controls were included in this cross-sectional study. Based on retrospective information provided by the patients, we evaluated changes in the severity of their OCD during the pandemic compared to the pre-pandemic period. We compared patients with OCD and healthy subjects using scores obtained from various scales.

Results: We found that symptom severity worsened in 60% of OCD patients during the pandemic compared to the pre-pandemic period, remained unchanged in 30%, and improved in 10%. The levels of obsession with COVID-19 were found to be higher in OCD patients than in healthy control subjects. The levels of fear of and obsession with COVID-19 both correlated with the anxiety levels of patients with OCD and healthy controls.

Conclusions: Our results suggest that the levels of COVID-19 related fear and obsession are not linked to the severity of OCD, but to anxiety levels. Key pointsObsessive-compulsive symptom severity worsened in 60% of OCD patients in the pandemic.COVID-19 obsession levels were higher in OCD patients than healthy controls.COVID-19 fear levels did not differ between the OCD and healthy control groups.COVID-19 obsession levels were correlated with anxiety severity in OCD and healthy control groups.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新冠肺炎疫情对强迫症患者的影响
目的:新冠肺炎疫情对强迫症(OCD)的影响尚不清楚。本研究的主要目的是调查大流行对强迫症患者的影响,以及临床特征与对COVID-19的恐惧和痴迷之间的关系。方法:本横断面研究共纳入30例连续的强迫症患者和30例年龄和性别匹配的健康对照。根据患者提供的回顾性信息,我们评估了与大流行前相比,他们在大流行期间强迫症严重程度的变化。我们比较强迫症患者和健康受试者使用从各种量表获得的分数。结果:我们发现,与大流行前相比,60%的强迫症患者在大流行期间症状严重程度加重,30%保持不变,10%改善。强迫症患者对COVID-19的痴迷程度高于健康对照组。对COVID-19的恐惧和痴迷程度都与强迫症患者和健康对照组的焦虑水平相关。结论:我们的研究结果表明,与COVID-19相关的恐惧和痴迷程度与强迫症的严重程度无关,而是与焦虑水平有关。在此次大流行中,60%的强迫症患者强迫症症状严重程度加重。强迫症患者对COVID-19的痴迷程度高于健康对照组。强迫症患者和健康对照组对COVID-19的恐惧程度没有差异。强迫症和健康对照组的COVID-19痴迷程度与焦虑严重程度相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.00
自引率
3.30%
发文量
42
审稿时长
>12 weeks
期刊介绍: International Journal of Psychiatry in Clinical Practice provides an international forum for communication among health professionals with clinical, academic and research interests in psychiatry. The journal gives particular emphasis to papers that integrate the findings of academic research into realities of clinical practice. Focus on the practical aspects of managing and treating patients. Essential reading for the busy psychiatrist, trainee and interested physician. Includes original research papers, comprehensive review articles and short communications. Key words: Psychiatry, Neuropsychopharmacology, Mental health, Neuropsychiatry, Clinical Neurophysiology, Psychophysiology, Psychotherapy, Addiction, Schizophrenia, Depression, Bipolar Disorders and Anxiety.
期刊最新文献
Mirtazapine blood levels and antidepressant response. Exploring real-world prescribing patterns for maintenance treatment in bipolar disorders: a focus on antidepressants and benzodiazepines. Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray. Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience. Neurobiological and psychological factors to depression.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1